• Shop
  • My Account
    • Cart
    • Checkout
HealthTopical
  • Home
  • Diet
  • Excercise
    • Yoga
  • Drug
  • Cancer
  • Eyes
  • Stretch Marks
  • Skin
  • Hair Loss
  • News
  • Contact Us!
No Result
View All Result
  • Home
  • Diet
  • Excercise
    • Yoga
  • Drug
  • Cancer
  • Eyes
  • Stretch Marks
  • Skin
  • Hair Loss
  • News
  • Contact Us!
No Result
View All Result
HealthTopical
No Result
View All Result
Home Cancer

Illumina Adds IBM Watson To DNA Test For Cancer Patients

Sristy by Sristy
January 9, 2017
in Cancer
0

(Photo by Ben Hider/Getty Images)

Illumina and IBM announced that they would be bundling IBM’s Watson Genomics product with Illumina’s TruSight Tumor 170, a tool used to help match very sick cancer patients with drugs that might help them.

The move is the latest effort by DNA sequencing companies to try to get doctors outside major cancer centers like Memorial Sloan-Kettering Cancer Center in New York or M.D. Anderson Cancer Center in Houston to try to scan patients’ DNA. The idea is that the DNA test results can be used to help patients who don’t have any options find medicines–either approved or experimental–that might help them. So far, this is considered standard practice for late-stage non-small cell lung cancer, but not for cancers in general.

Illumina says the sale of DNA sequencing machines for use in cancer represents about 10% of its annual sales, or about $240 million. That includes the sale of DNA sequencers to medical centers and to companies such as Foundation Medicine and NantHealth, which sell analysis of the genetic tools to health systems or patients.

Probably 2 million Americans could benefit from having their tumor DNA sequenced, according to Steve Harvey, vice president of Watson Health. Yet fewer than 10%, and probably more like 5%, do. The goal of the new partnership is to make it simpler for a hospital to start doing DNA sequencing. “Illumina’s ability to bundle the Watson report along with the TruSeq 170 enables a cancer institute or a diagnostic lab to get up and running much quicker,” says Harvey.

For doctors and hospitals, there are two big questions: Which genes do they sequence, and how do they analyze the resulting data? Often, the solution is a so-called “tumor board” in which a committee of doctors analyzes the genetic data patient by patient.

Recommended by Forbes

MOST POPULAR

Contents

  • 1 Photos: The Richest Person In Every State
  • 2 Thank You, Meryl Streep
Photos: The Richest Person In Every State

TRENDING ON FACEBOOK

Thank You, Meryl Streep
IBMVoice: How To Keep A Company’s Technology Systems Up And Running — After Disaster…

The IBM-Illumina offering is simpler: the DNA sequencer is used only to analyze the 170 genes in the tumor that indicate that a medicine that is either approved or available in clinical trials now might prove effective. Within minutes, Watson Genomics can take that data and put out a report that tells what genes are mutated and what drugs might help patients.

IBM points its experience using Watson at the University of North Carolina’s Lineberger Comprehensive Cancer Center, which was highlighted on a recent episode of 60 Minutes, the news magazine show. Watson always found the mutations that the tumor board settled on, it says. But in 30% of cases Watson also found other mutated genes, which the tumor board agreed were important.

[“source-smallbiztrends”]

Tags: AddsCancerDNAforIBMIlluminapatientsTesttoWatson
Previous Post

Using immune cells to deliver anti-cancer drugs

Next Post

‘Too sexy for cancer’ t-shirts are empowering patients

Next Post

‘Too sexy for cancer’ t-shirts are empowering patients

No Result
View All Result

Get Daily Update Via Mail

Follow me on Twitter

My Tweets

Like Us !

Like Us !
HealthTopical

© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.

Navigate Site

  • Unlocking the Secrets to Clear
  • Privacy Policy
  • Contact Us!

Follow Us

No Result
View All Result
  • Home
  • Diet
  • Excercise
    • Yoga
  • Drug
  • Cancer
  • Eyes
  • Stretch Marks
  • Skin
  • Hair Loss
  • News
  • Contact Us!

© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.